ArticleJournal of thoracic disease2017
Twice-daily chemoradiotherapy must still be the choice for patients with limited-stage small-cell lung cancer.
Fernando Franco et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it